In epidermal growth factor receptor mutant non-small cell lung cancer, the interaction of integrin αvβ3 with OPN promotes acquired resistance to tyrosine kinase inhibitors of the growth factor receptor by activating the downstream FAK/protein kinase B and ERK signaling pathways [51]. The gene discussed is SPP1; the disease is non-small cell lung carcinoma.